Cargando…
Intravitreal aflibercept for exudative age-related macular degeneration with good visual acuity: 2-year results of a prospective study
PURPOSE: We report the 2-year outcomes of intravitreal aflibercept (IVA) for exudative age-related macular degeneration (AMD) with good visual acuity (VA) and examine the baseline factors associated with good visual outcome. MATERIALS AND METHODS: This multicenter, prospective study evaluated 39 eye...
Autores principales: | Sakamoto, Shinichi, Takahashi, Hidenori, Inoue, Yuji, Arai, Yusuke, Inoda, Satoru, Kakinuma, Natsuko, Fujino, Yujiro, Tanabe, Tatsuro, Kawashima, Hidetoshi, Yanagi, Yasuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022819/ https://www.ncbi.nlm.nih.gov/pubmed/29970955 http://dx.doi.org/10.2147/OPTH.S160961 |
Ejemplares similares
-
Visual acuity loss associated with excessive “dry macula” in exudative age-related macular degeneration
por: Takahashi, Hidenori, et al.
Publicado: (2018) -
Efficacy of a Modified Treat-and-Extend Aflibercept Regimen for Macular Oedema in Eyes with Central Retinal Vein Occlusion: 2-Year Prospective Study
por: Arai, Yusuke, et al.
Publicado: (2023) -
An AI model to estimate visual acuity based solely on cross-sectional OCT imaging of various diseases
por: Inoda, Satoru, et al.
Publicado: (2023) -
Efficacy of Modified Treat-and-Extend Aflibercept Regimen for Macular Edema Due to Branch Retinal Vein Occlusion: 1-Year Prospective Study
por: Arai, Yusuke, et al.
Publicado: (2020) -
Efficacy of Modified Treat-and-Extend Regimen of Aflibercept for Macular Edema from Branch Retinal Vein Occlusion: 2-Year Prospective Study Outcomes
por: Arai, Yusuke, et al.
Publicado: (2021)